H2 POLYMED
ActiveSummary
H2 POLYMED has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €715,784 and a net result of €379,137. Equity is growing by about 95% per year across the filed financial years. Its solvency ranks better than 40% of 2,952 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
22-07
NBB filing
Annual accounts filed
financial year 2025 · abbreviated format
2025
31-12
Financial
Highest result from 2023 to 2025net €379,137 ▲44.7%
Operating result €551,081, net result €379,137, both a record.
31-12
Financial
Equity above €500,000equity €715,784 ▲113%
A profit in every financial year since 2023 builds equity to €715,784.
30-08
NBB filing
Annual accounts filed
financial year 2024 · micro format · 30 days late
2024
31-12
Financial
Equity above €200,000equity €336,647 ▲351%
A profit in every financial year since 2023 builds equity to €336,647.
29-08
NBB filing
Annual accounts filed
financial year 2023 · micro format · 29 days late
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
0 of 1 deed read
About the unread acts
We know of 1 Belgian Official Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.